Versartis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Versartis and buy or sell other stocks, ETFs, and their options commission-free!About VSAR
Aravive, Inc. operates as a clinical stage biotechnology company, which engages in the development of transformative treatments designed to halt the progression of life threatening disease, including cancer and fibrosis. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
CEOGail Frances McIntyre, PhD
CEOGail Frances McIntyre, PhD
Employees—
Employees—
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2008
Founded2008
Employees—
Employees—
VSAR Key Statistics
Market cap2.95M
Market cap2.95M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume749.68K
Average volume749.68K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.46
52 Week high$2.46
52 Week low$0.04
52 Week low$0.04
Stock Snapshot
With a market cap of 2.95M, Versartis(VSAR) trades at $8.51. The stock has a price-to-earnings ratio of -0.04.
On 2025-12-15, Versartis(VSAR) stock opened at —, reached a high of —, and a low of —.
The Versartis(VSAR)'s current trading volume is 0, compared to an average daily volume of 749.68K.
In the last year, Versartis(VSAR) shares hit a 52-week high of $2.46 and a 52-week low of $0.04.
In the last year, Versartis(VSAR) shares hit a 52-week high of $2.46 and a 52-week low of $0.04.